Takahiro Koyanagi

8PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 07, 2026
Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

|Mar 01, 2026
Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma.

Yoshifumi Takahashi, Yuji Takei, Miku Takadera

|Apr 24, 2025
Progesterone Enhances Sensitivity of Ovarian Cancer Cells to SN38 Through Inhibition of Topoisomerase I and Inducing Ferroptosis.

Takahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi

|Dec 22, 2024
Forced Vasohibin-1 Expression Increases Paclitaxel Sensitivity of Ovarian Cancer by Inhibiting Microtubule Activity.

Takahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi

|Aug 29, 2024
Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration.

Kohei Tamura, Natsuka Kimura, Hideyuki Ohzawa

|Aug 09, 2024
Cervical cancer screening efficacy using SurePath, ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society.

Takahiro Koyanagi, Hiroyuki Fujiwara, Kouji Yamamoto

Pageof 2

Frequent Collaborators

2 joint publications

Hiroyuki Fujiwara

2 joint publications

Yoshifumi Takahashi

1 joint publications

Naohiro Sata

1 joint publications

Joji Kitayama